SCHEMBL2013937

SCHEMBL2013937

Cc1cccc(C(=O)NCCC(Cc2ccccc2)N(C)C(=O)c2coc3ccccc23)n1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.43
HCRTR2 O43614 2/20 0.43
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
MAOB P27338 2/20 0.38
KMT2A Q03164 2/20 0.38
HPGD P15428 2/20 0.36
MEN1 O00255 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRK1 P41145 1/20 0.36
TMEM97 Q5BJF2 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
HTT P42858 1/20 0.36
P2RX7 Q99572 1/20 0.35
ALDH1A1 P00352 1/20 0.34
CTSA P10619 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2054334 1.00 HCRTR1 (0.43) HCRTR1HCRTR2KDM4ELMNAMAOB
SCHEMBL2013932 0.89 KMT2A (0.40) HCRTR1HCRTR2KDM4ELMNAMAOB
SCHEMBL2053123 0.89 KMT2A (0.40) HCRTR1HCRTR2KDM4ELMNAMAOB
SCHEMBL2013146 0.81 HCRTR1 (0.66) HCRTR1HCRTR2MAOBKMT2APTGDR2
SCHEMBL2051392 0.81 HCRTR1 (0.66) HCRTR1HCRTR2MAOBKMT2APTGDR2
SCHEMBL2016670 0.80 HCRTR1 (0.40) HCRTR1HCRTR2KDM4ELMNAMAOB
SCHEMBL6918283 0.80 HCRTR1 (0.40) HCRTR1HCRTR2KDM4ELMNAMAOB
SCHEMBL2014119 0.80 HCRTR1 (0.59) HCRTR1HCRTR2MAOBKMT2ANPC1
SCHEMBL6919529 0.79 EPHX2 (0.44) HCRTR1HCRTR2KMT2AMEN1ALDH1A1
SCHEMBL2012479 0.79 EPHX2 (0.44) HCRTR1HCRTR2KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed